Study outlines targeted treatment option for aggressive breast cancer

by University of MarylandMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainNew findings put forth by the University of Maryland Fischell Department

Updated on: March 01,2024

Study outlines targeted treatment option for aggressive breast cancer

by University of MarylandMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainNew findings put forth by the University of Maryland Fischell Department

Updated on:March 01,2024

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A

Updated on: May 25,2024

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A

Updated on:May 25,2024

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th

Updated on: February 18,2024

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th

Updated on:February 18,2024

Target discovered for the treatment of pancreatic cancer

byKiel UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA team at the Institute of Biochemistry at Kiel University has found a

Updated on: July 05,2024

Target discovered for the treatment of pancreatic cancer

byKiel UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA team at the Institute of Biochemistry at Kiel University has found a

Updated on:July 05,2024

Poor oral health linked to a 75% increase in liver cancer risk, new study finds

by SAGE PublicationsCredit: CC0 Public DomainThe study, by researchers at Queen's University Belfast, analysed a large cohort of over 469,000 people in the UK, investigated the association be

Updated on: May 21,2024

Poor oral health linked to a 75% increase in liver cancer risk, new study finds

by SAGE PublicationsCredit: CC0 Public DomainThe study, by researchers at Queen's University Belfast, analysed a large cohort of over 469,000 people in the UK, investigated the association be

Updated on:May 21,2024

A new blood test could detect early stage melanoma in more than 80% of patients

by Mel Ziman,The ConversationCredit: AI-generated imageMelanoma killsmore than 1,700 Australians every year, which is more than thenational road toll. But the good news is it's t

Updated on: May 21,2024

A new blood test could detect early stage melanoma in more than 80% of patients

by Mel Ziman,The ConversationCredit: AI-generated imageMelanoma killsmore than 1,700 Australians every year, which is more than thenational road toll. But the good news is it's t

Updated on:May 21,2024

Moderate delays safe in treating colon cancer

by Paul Mayne,University of Western OntarioSchulich School of Medicine & Dentistry medical resident Dr. Kerollos Wanis, left, assists Drs. David Bottoni and Robert Black with a cancer-resect

Updated on: April 09,2024

Moderate delays safe in treating colon cancer

by Paul Mayne,University of Western OntarioSchulich School of Medicine & Dentistry medical resident Dr. Kerollos Wanis, left, assists Drs. David Bottoni and Robert Black with a cancer-resect

Updated on:April 09,2024

New screening tool to explore mechanisms behind cancer, autoimmunity and neurodegeneration

by Jelena Pupavac,Wellcome Trust Sanger InstituteA single-cell base editor screen tiling acrossJAK1is improved by coupling genotype with transcriptome.aUMAP of LoF and no

Updated on: April 23,2024

New screening tool to explore mechanisms behind cancer, autoimmunity and neurodegeneration

by Jelena Pupavac,Wellcome Trust Sanger InstituteA single-cell base editor screen tiling acrossJAK1is improved by coupling genotype with transcriptome.aUMAP of LoF and no

Updated on:April 23,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on: January 16,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on:January 16,2024

Immune targets for chemotherapy-resistant breast cancers identified

byKing's College LondonAnalysis of stromal TILs in residual disease and prognostic implications. A) Kaplan–Meier curves for i) progression free survival and ii) overall survival in ER+HER2-

Updated on: January 02,2024

Immune targets for chemotherapy-resistant breast cancers identified

byKing's College LondonAnalysis of stromal TILs in residual disease and prognostic implications. A) Kaplan–Meier curves for i) progression free survival and ii) overall survival in ER+HER2-

Updated on:January 02,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on: April 06,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on:April 06,2024

Researchers characterize mechanism of action of CAR T cells

by H. Lee Moffitt Cancer Center & Research InstituteScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDThe sci

Updated on: June 08,2024

Researchers characterize mechanism of action of CAR T cells

by H. Lee Moffitt Cancer Center & Research InstituteScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDThe sci

Updated on:June 08,2024